Who owns Crescent Biopharma Inc?
- Ticker: CBIO
- CUSIP Number: g2545c104
Tip: Access positions for across all investors
Analyze quarterly positions in Crescent Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Crescent Biopharma stock
Who bought or sold Crescent Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 1.4M | $17M | 0% | Sep 2025 |
|
| Fairmount Funds Management | 1.4M | $17M | 0% | Sep 2025 |
|
| VR Adviser | 1.4M | $17M | 0% | Sep 2025 |
|
| BVF | 1.4M | $17M | 0% | Sep 2025 |
|
| Tang Capital Management | 680k | $8.1M | 1256% | Sep 2025 |
|
| Vanguard Group | 658k | $7.8M | 100% | Sep 2025 |
|
| Logos Global Management | 600k | $7.1M | 8% | Sep 2025 |
|
| Deep Track Capital | 454k | $5.4M | 0% | Sep 2025 |
|
| Boxer Capital Management | 454k | $5.4M | 0% | Sep 2025 |
|
| Perceptive Advisors | 454k | $5.4M | 0% | Sep 2025 |
|
| Commodore Capital | 451k | $5.4M | -1% | Sep 2025 |
|
| Driehaus Capital Management | 303k | $3.6M | 0% | Sep 2025 |
|
| Frazier Life Sciences Management | 273k | $3.2M | -40% | Sep 2025 |
|
| Adage Capital Partners GP | 200k | $2.4M | 98% | Sep 2025 |
|
| Soleus Capital Management | 200k | $2.4M | -50% | Sep 2025 |
|
| BlackRock | 109k | $1.3M | 1703% | Sep 2025 |
|
| Leucadia National Corporation | 103k | $1.2M | 279% | Sep 2025 |
|
| Blackstone Group | 76k | $899k | 0% | Sep 2025 |
|
| Geode Capital Management | 69k | $822k | 100% | Sep 2025 |
|
| Marshall Wace | 44k | $520k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 37k | $440k | 100% | Sep 2025 |
|
| Two Sigma Investments | 28k | $337k | 100% | Sep 2025 |
|
| Renaissance Technologies | 27k | $320k | 100% | Sep 2025 |
|
| Citadel Advisors | 26k | $304k | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 25k | $296k | 100% | Sep 2025 |
|
| State Street Corporation | 19k | $221k | 100% | Sep 2025 |
|
| Affinity Asset Advisors | 18k | $214k | -94% | Sep 2025 |
|
| Wellington Management Company | 18k | $210k | -90% | Sep 2025 |
|
| Northern Trust | 17k | $200k | 100% | Sep 2025 |
|
| Morgan Stanley | 15k | $248k | 100% | Jun 2025 |
|
| UBS Group | 13k | $151k | 5578% | Sep 2025 |
|
| Tower Research Capital | 200.00 | $2.4k | 100% | Sep 2025 |
|
| Group One Trading | 82.00 | $974.996400 | -49% | Sep 2025 |
|
| SBI Securities | 68.00 | $809.002800 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 26.00 | $373.999600 | 100% | Sep 2025 |
|
| Royal Bank of Canada | 20.00 | $0 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 17.00 | $202.000800 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $48.000000 | 0% | Sep 2025 |
|
Who sold out of Crescent Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Paradigm Biocapital Advisors | Jun 2025 | 643k | $10M |
| Braidwell | Jun 2025 | 262k | $4.2M |
| Barclays | Jun 2025 | 286.00 | $3.8k |
| Raymond James Financial | Jun 2025 | 50.00 | $807.000000 |